FEATURED EDITORIAL
Understanding the full scope of the life science industry has never been more critical. Ray Dogum, Chief Editor of Drug Discovery Online, joins the Life Science Connect Editors’ Roundtable on a special episode of Better Biopharma podcast.
- Engineering Therapeutics With A Structural Approach
- Room For Improvement: Reformulating Existing Therapeutics
- Harnessing Mitochondria: A New Frontier In Therapeutic Innovation
- The Unlikely Weapon Against Fentanyl: Your Immune System
- Partnering For Progress: Funding The Future Of Rare Disease Research
- In Vivo LNP-Engineered Cytokine-Armored CAR Cells For Solid Tumors
- Small Molecule Enzyme Mimetics In Age-Related Neurodegeneration
FEATURED APPLICATION CONTENT
-
Scalable lentiviral vector production is moving beyond adherent systems. Learn how streamlined workflows enable linear scale-up in stirred-tank bioreactors for cost-effective gene therapy manufacturing.
-
Decoding immune cell interactions reveals critical insights for cancer therapy. Advanced imaging and spectral analysis enable precise identification of synapses, accelerating immuno-oncology research.
-
Explore how efficient powder-liquid mixing and sterile filtration preserve media integrity and support reproducibility in biopharmaceutical workflows, with promising scalability for larger-volume applications.
-
Explore how particle levels remained stable during 24 hours of high-speed mixing, even under extreme temperatures, confirming a system’s suitability for final fill and other particulate-sensitive applications.
-
Explore how a modular AAV8 platform enables scalable, GMP-ready gene therapy manufacturing with reproducible outcomes, streamlined tech transfer, and adaptability across serotypes.
-
Discover how a CDMO achieved 40x productivity and 15% cost savings by switching to rapid cycling membrane chromatography for ADC polishing, which helped cut process time and buffer use.
-
Continuous biomanufacturing is reshaping how active pharmaceutical ingredients are produced. Learn how modular, automated virus inactivation solutions are helping manufacturers improve efficiency.
-
Explore how digital tools are advancing peptide purification, with a focus on GLP-1 receptor agonists, as well as how process efficiency can be accelerated through real-time insights.
-
Gain insight into how consolidating downstream operations into a single automated system can reduce footprint, cut processing time, and minimize manual errors to help teams work more efficiently.
-
Explore a scalable AAV production platform that improves full capsid yield and dramatically reduces host cell impurities, offering a practical solution to common manufacturing challenges.
-
Discover scalable strategies for overcoming AAV purification challenges, from low yield and impurity removal to serotype variability, as well as how advanced tools can streamline manufacturing.
-
Process intensification demands smarter orchestration, real-time analytics, and scalable automation. Discover how digital infrastructure enables synchronized, compliant, and predictive biomanufacturing.
- Annual Reflections And Predictions From The Editors' Roundtable
- The Unlikely Weapon Against Fentanyl: Your Immune System
- 2025's Top 5 Drug Discovery Highlights And How To Stay Ahead In 2026
- GO‑4 Drug Combo Offers New Hope for Treating Late-Stage BRCA/PALB2-Mutated Cancers
- From Funding Gaps to AI Frontiers: Insights from the Boston Globe Summit 2025
FEATURED NEWS HEADLINES
- Axsome Therapeutics Announces FDA Acceptance And Priority Review Of Supplemental New Drug Application For AXS-05 For The Treatment Of Alzheimer's Disease Agitation
- Cogent Biosciences Announces Submission Of New Drug Application For Bezuclastinib In Nonadvanced Systemic Mastocytosis
- New Computational Method 'Fast-Tracks' Drug Discovery
- Sinopia Biosciences Awarded NIGMS Grant To Advance LEADS Platform For Data-Driven Drug Discovery
- OHSU Researchers Find Breast Cancer Drug Boosts Leukemia Treatment
- Unicycive Therapeutics Announces Resubmission Of New Drug Application (NDA) For Oxylanthanum Carbonate (OLC)
- Harbour Biomed Enters Into Long-Term Strategic Collaboration With Lannacheng To Advance Next-Generation Radionuclide Drug Conjugates
- CARsgen Submits Dual IND Applications For Allogeneic BCMA CAR-T Product CT0596
- Caliway's Fat Reduction Drug Candidate CBL-514 Completes U.S. FDA IND Submission For Phase 2 Clinical Study In Weight Management, Expanding Development Combined With GLP-1RA-Based Weight-Loss Therapies
- Zai Lab Announces Approval Of COBENFY (xanomeline And trospium chloride) In China, A First-In-Class Therapy For Schizophrenia
ARCHIVED NEWSLETTER
- 01.06.26 -- The Unlikely Weapon Against Fentanyl: Your Immune System
- 12.23.25 -- 2025's Top 5 Drug Discovery Highlights And How To Stay Ahead In 2026
- 12.16.25 -- Returning To Nature: Discovering The Next Generation Of Medicines
- 12.09.25 -- When Preclinical Models Distort The Patient
- 12.01.25 -- Better Outcomes, Faster: PBPK Modeling For Absorption & Solid Form Security